65 results
8-K
EX-99.1
ALLK
Allakos Inc
16 Jan 24
Regulation FD Disclosure
6:17pm
website at www.sec.gov. This presentation concerns products that are under clinical investigation, and which have not yet been approved for marketing
8-K
EX-99.2
ALLK
Allakos Inc
19 Sep 22
Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock
7:14am
concerns products that are under clinical investigation and which have not yet been approved for marketing by the U.S. Food and Drug Administration
8-K
EX-1.1
ojxpz
19 Sep 22
Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock
7:14am
8-K
EX-1.1
mp17qgiixzan ei8
4 Aug 22
Entry into a Material Definitive Agreement
5:31pm
8-K
EX-99.1
uebtej
21 Jun 22
Other Events
5:08pm
8-K
EX-10.1
mwcz7tpvintru82 s3q3
20 Apr 22
Departure of Directors or Certain Officers
4:02pm
8-K/A
EX-99.1
5bz4918emipmde7sj1e
15 Feb 22
Other Events
10:02am
8-K
EX-99.1
uwta 3qpp4
15 Feb 22
Other Events
8:00am
8-K
EX-1.1
kwb1x7
10 May 21
Entry into a Material Definitive Agreement
4:56pm